MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ygyno.2022.01.013

Медицинская библиотека · Gynecologic oncology · 2022

Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.

Raffone Antonio, Travaglino Antonio, Raimondo Diego, Neola Daniele, Maletta Manuela, Santoro Angela, Insabato Luigi, Casadio Paolo, Fanfani Francesco, Zannoni Gian Franco, Zullo Fulvio, Seracchioli Renato, Mollo Antonio

СтатьяМетаанализСистематический обзорПеревод пока не подготовлен

Аннотация

BACKGROUND

The 2020 ESGO/ESTRO/ESP guidelines stratify the prognosis of endometrial carcinoma (EC) patients combining The Cancer Genome ATLAS (TCGA) molecular signature and pathological factors, including lymphovascular space invasion (LVSI). However, little is known about the prognostic independence of LVSI from molecular signature.

AIM: To assess whether the prognostic value of LVSI is independent from the TCGA signature.

MATERIAL AND

METHODS

A systematic review and meta-analysis was performed by searching 5 electronic databases from their inception to March 2021. All peer-reviewed studies reporting assessing LVSI as a prognostic factor independent from the TCGA groups in EC were included. Multivariate HRs with 95% confidence interval (CI) were pooled separately for overall survival (OS), disease-specific survival (DSS) and disease-free survival (DFS). The absence of LVSI was considered as a reference. In DFS analyses, locoregional and distant recurrence were separately considered for one study.

RESULTS

Six studies with 3331 patients were included in the systematic review and three studies with 2276 patients in the meta-analysis. LVSI showed a pooled multivariate HR of 1.818 (CI 95%, 1.378-2.399) for OS, 1.849 (CI 95%, 1.194-2.863) for DSS, 1.377 (CI 95%, 1.008-1.880) for DFS excluding one study, 1.651 (CI 95%, 1.044-2.611) for DFS additionally considering locoregional recurrence from one study, and 1.684 (CI 95%, 1.05-2.701) for DFS additionally considering distant recurrence from the same study.

CONCLUSION

LVSI has a prognostic value independent of TCGA signature, as well as age and adjuvant treatment, increasing the risk of death of any cause, death due to EC and recurrent or progressive disease by 1.5-2 times.

Для цитирования: Raffone Antonio, Travaglino Antonio, Raimondo Diego, Neola Daniele, Maletta Manuela, Santoro Angela, Insabato Luigi, Casadio Paolo, Fanfani Francesco, Zannoni Gian Franco, Zullo Fulvio, Seracchioli Renato, Mollo Antonio. Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature.. Gynecologic oncology. 2022. DOI: 10.1016/j.ygyno.2022.01.013.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.